HIV News
-
For patients with HIV viral load is key in immune response to yellow fever vaccine
-
Contraception in HIV prevention trials: injectable hormonal methods more effective?
-
Men who have sex with men may now be the highest-risk group for HIV in Africa, IAVI study suggests
-
HIV care providers in US struggling to cope with rising patient numbers
-
Quarter of men resume sex before wounds from circumcision fully healed in Zambian study
-
Raltegravir/Truvada HIV PEP regimen well tolerated with no infections after its use
-
For study participants, PrEP was an opportunity to save their relationship
-
Majority of HIV-positive patients in US not receiving regular medical care
-
Hormonal contraception and HIV risk: no increased risk in South African cohort
-
Rapid HIV test performance poorer with oral fluid than blood, especially when prevalence is low
HIV in the news
For patients with HIV viral load is key in immune response to yellow fever vaccine
Contraception in HIV prevention trials: injectable hormonal methods more effective?
Men who have sex with men may now be the highest-risk group for HIV in Africa, IAVI study suggests
HIV care providers in US struggling to cope with rising patient numbers
Quarter of men resume sex before wounds from circumcision fully healed in Zambian study
Raltegravir/Truvada HIV PEP regimen well tolerated with no infections after its use
Entries (RSS) Comments (RSS)